Novel Human-Derived RET Fusion NSCLC Cell Lines Have Heterogeneous Responses to RET Inhibitors and Differential Regulation of Downstream Signaling
Laura Schubert(University of Colorado Anschutz Medical Campus), Robert C. Doebele(University of Colorado Anschutz Medical Campus)
Cited by 10
Related Papers
An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer
|Journal of Thoracic Oncology|2016|81
Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC
|npj Precision Oncology|2021|11